Site Menu

News Center

Press releases

December 12, 2017

Aprecia Pharmaceuticals and Cycle Pharmaceuticals Partner to Develop 3D-Printed Orphan Drugs

November 1, 2017

Aprecia Pharmaceuticals Names University of Kentucky Provost as the Company’s Next CEO

September 7, 2017

Prasco Affiliate Acquires Larger Stake in Aprecia

July 5, 2016

Aprecia Pharmaceuticals Secures up to $30 Million from Hercules Capital

March 22, 2016

First FDA-Approved Medicine Manufactured Using 3D Printing Technology Now Available

January 27, 2016

Aprecia Set to Advance Pipeline with Completion of $35 Million Financing

August 3, 2015

FDA Approves the First 3D Printed Drug Product

February 23, 2015

Aprecia Pharmaceuticals Bringing Jobs to Blue Ash

December 9, 2014

Aprecia Pharmaceuticals Receives FDA Acceptance for Filing for First Product Using Advanced ZipDose® Technology

November 6, 2013

Aprecia Welcomes Don Wetherhold as Its Chief Executive Officer


July 15, 2014

3D Printing Set to Revolutionize Pharma

Media inquiries

For media inquiries, please e-mail us at

General inquiries

For general inquiries, please e-mail us at